Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 55 citing articles:

Citrullination and autoimmunity
Guido Valesini, Maria Chiara Gerardi, Cristina Iannuccelli, et al.
Autoimmunity Reviews (2015) Vol. 14, Iss. 6, pp. 490-497
Closed Access | Times Cited: 238
Autoinflammation and autoimmunity: Bridging the divide
Andrea Doria, Margherita Zen, Silvano Bettio, et al.
Autoimmunity Reviews (2012) Vol. 12, Iss. 1, pp. 22-30
Closed Access | Times Cited: 210
Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis
Leendert A. Trouw, Michael Mähler
Autoimmunity Reviews (2012) Vol. 12, Iss. 2, pp. 318-322
Closed Access | Times Cited: 135
Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis
Sara de Brito Rocha, Danielle Cristiane Baldo, Luís Eduardo Coelho Andrade
Advances in Rheumatology (2019) Vol. 59, Iss. 1
Open Access | Times Cited: 123
Anti-citrullinated peptides as autoantigens in rheumatoid arthritis—relevance to treatment
Lazaros I. Sakkas, Dimitrios P. Bogdanos, Christina G. Katsiari, et al.
Autoimmunity Reviews (2014) Vol. 13, Iss. 11, pp. 1114-1120
Closed Access | Times Cited: 118
Autoantibodies in inflammatory arthritis
Paola Conigliaro, Maria Sole Chimenti, Paola Triggianese, et al.
Autoimmunity Reviews (2016) Vol. 15, Iss. 7, pp. 673-683
Open Access | Times Cited: 105
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study
Nicola Bizzaro, Elena Bartoloni, Gabriella Morozzi, et al.
Arthritis Research & Therapy (2013) Vol. 15, Iss. 1
Open Access | Times Cited: 77
Biomarkers in Rheumatoid Arthritis
Samantha C. Shapiro
Cureus (2021)
Open Access | Times Cited: 47
Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care
Ola A. Al-Ewaidat, Moawiah M. Naffaa
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectives
Britt Nakken, Gábor Papp, Vidar Bosnes, et al.
Immunology Letters (2017) Vol. 189, pp. 13-18
Closed Access | Times Cited: 59
Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features
Zyanya Reyes-Castillo, Claudia Azucena Palafox‐Sánchez, Isela Parra‐Rojas, et al.
Clinical & Experimental Immunology (2015) Vol. 182, Iss. 2, pp. 119-131
Open Access | Times Cited: 56
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis
Francesco Carubbi, Alessia Alunno, Roberto Gerli, et al.
Cells (2019) Vol. 8, Iss. 7, pp. 657-657
Open Access | Times Cited: 43
Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis
Alessia Alunno, Onelia Bistoni, Federico Pratesi, et al.
Lara D. Veeken (2018) Vol. 57, Iss. 5, pp. 850-855
Open Access | Times Cited: 40
Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis
Andreas Swart, Rufus W. Burlingame, Irmgard Gürtler, et al.
Clinica Chimica Acta (2012) Vol. 414, pp. 266-272
Open Access | Times Cited: 39
Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population
Zoltán Szekanecz, Zoltán Szabó, Margit Zeher, et al.
Immunologic Research (2013) Vol. 56, Iss. 2-3, pp. 439-443
Closed Access | Times Cited: 37
Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis
Young Ho Lee, Sang‐Cheol Bae, Gwan Gyu Song
Zeitschrift für Rheumatologie (2015) Vol. 74, Iss. 10, pp. 911-918
Closed Access | Times Cited: 37
Clinical Guidelines and Definitions of Autoinflammatory Diseases: Contrasts and Comparisons with Autoimmunity—a Comprehensive Review
Margherita Zen, Mariele Gatto, Marta Domeneghetti, et al.
Clinical Reviews in Allergy & Immunology (2013) Vol. 45, Iss. 2, pp. 227-235
Closed Access | Times Cited: 36
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study
Claudio Tirelli, Valentina Morandi, Adele Valentini, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 26
Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris
Szandra Dalmády, Mária Kiss, László Képíró, et al.
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-9
Open Access | Times Cited: 30
Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis
Carl Turesson, Linda Mathsson, L. Jacobsson, et al.
Annals of the Rheumatic Diseases (2013) Vol. 72, Iss. 12, pp. 2047-2048
Closed Access | Times Cited: 30
Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients
Tao Zhu, Liyun Feng
International Journal of Rheumatic Diseases (2013) Vol. 16, Iss. 2, pp. 157-161
Closed Access | Times Cited: 27
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features
Cristiano Alessandri, Nancy Agmon‐Levin, Fabrizio Conti, et al.
Immunologic Research (2017) Vol. 65, Iss. 2, pp. 524-531
Closed Access | Times Cited: 21
Anti-MCV and anti-CCP antibodies—diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA)
Joanna Lipińska, S Lipińska, Marek Kasielski, et al.
Clinical Rheumatology (2016) Vol. 35, Iss. 11, pp. 2699-2706
Closed Access | Times Cited: 20
Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests
María Infantino, Mariangela Manfredi, Francesca Meacci, et al.
Clinica Chimica Acta (2014) Vol. 436, pp. 237-242
Closed Access | Times Cited: 21
Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
Miriam Lizette Díaz-Toscano, Eva Maria Olivas-Flores, Soraya Amalí Zavaleta Muñiz, et al.
BioMed Research International (2014) Vol. 2014, pp. 1-6
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top